CalciMedica (CALC) Other Non Operating Income (2022 - 2026)

CalciMedica's (CALC) quarterly Other Non Operating Income came in at -$1000.0 in Q4 2025, down 100.37% on a QoQ basis from $269000.0 in Q2 2025.

CalciMedica (CALC) Other Non Operating Income (2022 - 2026) Analysis & Trends

CalciMedica (CALC) has 4 years of Other Non Operating Income data on file, last reported at -$1000.0 in Q4 2025.

Quarterly Other Non Operating Income changed N/A year-over-year to -$1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $268000.0 (down 12.7% YoY) and the FY2025 annual result came in at $268000.0, changed N/A from the prior year.
Other Non Operating Income slipped to -$1000.0 in Q4 2025, from $269000.0 in the prior quarter.
In the past five years, Other Non Operating Income ranged from a high of $307000.0 in Q1 2024 to a low of -$116000.0 in Q1 2023.
A 4-year average of $109700.0 and a median of $111500.0 in 2022 frame the typical range for Other Non Operating Income.
The widest YoY moves for Other Non Operating Income: up 1062.07% in 2023, down 246.0% in 2023.
Tracing CALC's Other Non Operating Income over 4 years: stood at $50000.0 in 2022, then surged by 246.0% to $173000.0 in 2023, then jumped by 77.46% to $307000.0 in 2024, then sank by 100.33% to -$1000.0 in 2025.
The last three Other Non Operating Income figures came in at -$1000.0 (Q4 2025), $269000.0 (Q2 2025), and $307000.0 (Q1 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	CalciMedica	9.80 Mn	-8.82 Mn	-

Download Data